Author
Listed:
- Marlen Vasconcelos Alves Melo
- Marcelo Adrian Estrin
Abstract
Hypertensive disorders during pregnancy are a major cause of severe illness, long-term disability, and maternal mortality. Preeclampsia is considered one of the main diseases associated with these disorders, and it is important to know how to facilitate its prevention through early detection to achieve adequate clinical management. In this context, it has been proven that knowledge of risk factors, the quality of follow-up of these patients, early diagnosis and appropriate clinical management have a significant impact on minimizing these data. To unify, analyze and identify the available evidence about the possible benefits and risks of the preventive therapies available for the treatment of preeclampsia, to define the current level of evidence of this therapy and the effects on the clinical results of maternal and child health. Data collection was performed through a search in the online databases: SciELO (Scientific Electronic Library Online) and PUBMED. The articles were downloaded from the cited platforms, and Zotero program was used to make the proper citations and references. The research will be made up of published and updated literature that reflects the importance and types of preventive treatment in preeclampsia. Results and discusión: Fifteen studies that met the criteria related to the object of study were included. According to the results achieved, the study allowed obtaining a more detailed view of the studies that emerged from the data search, highlighting categories such as those that reflect knowledge of non-pharmacological and pharmacological treatments and their real effectiveness for the prevention of preeclampsia. The analysis carried out shows that the findings of this study suggest that carrying out interventions for the prevention of preeclampsia in general is beneficial when the components that have a proven positive effect are mainly used. Abbreviations: (AIT) Alanine aminotransferase, (AST) Aspartate Aminotransferase, (UIL) Intrauterine growth restriction, (DIC) Disseminated intravascular coagulation, (PE) Preeclampsia
Suggested Citation
Handle:
RePEc:dbk:procee:v:1:y:2023:i::p:1056294piii2023164:id:1056294piii2023164
Download full text from publisher
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below whether another version of this item is available online.
2. Check on the provider's
web page
whether it is in fact available.
3. Perform a
for a similarly titled item that would be
available.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:procee:v:1:y:2023:i::p:1056294piii2023164:id:1056294piii2023164. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://proceedings.ageditor.ar/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.